{
    "clinical_study": {
        "@rank": "4763", 
        "arm_group": {
            "arm_group_label": "Patients with Hyperparathyroidism", 
            "description": "The cohort of patients is made of patients with primary mild hyperparathyroidism and who have received a surgery at Nantes, Angers, Limoges or Marseille University Hospitals"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the evolution of the non specific symptoms for 116\n      patients with mild primary hyperparathyroidism before and 3, 6 and 12 months after surgery.\n      A clinical score predicting clinical improvement at one year will be created."
        }, 
        "brief_title": "Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary Hyperparathyroidism", 
        "completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "condition": "Primary Hyperparathyroidism", 
        "condition_browse": {
            "mesh_term": [
                "Hyperparathyroidism", 
                "Hyperparathyroidism, Primary"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with known moderate HPTI will be considered for participation.\n\n        Patients with sporadic mild HPTI defined by:\n\n          -  calcemia > 2.6 mmol/L , PTH  > 25 ng/L and  creatininemia < 160\u00b5mol/L OR\n\n          -  calcemia between 2.5 and 2.6 mmol/L and PTH  >  35 ng/L\n\n          -  calcemia \u22642.85 mmol/L\n\n          -  urine calcium level / 24 hours < 10 mmol (400 mg),\n\n          -  decrease of the creatinin's clearance : 30%  lower than normal population with the\n             same age\n\n          -  patients younger than 50\n\n          -  patients  who can't be followed\n\n        Exclusion Criteria:\n\n          -  familial hypercalcemia\n\n          -  multiple endocrinal neoplasia\n\n          -  treatment with lithium or thiazides\n\n          -  impossibility for the patient to complete the forms\n\n          -  impossibility to follow the patient\n\n          -  patient with serious disease which impact the quality of life"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "A prospective, non randomized, open, multicenter trial to evaluate non specific symptoms\n        and quality of life (SF 36) before and after surgery for mild primary hyperparathyroidism"
            }
        }, 
        "enrollment": {
            "#text": "116", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01776502", 
            "org_study_id": "RC12_0255"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 23, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "49100"
                    }, 
                    "name": "Angers University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87000"
                    }, 
                    "name": "Limoges University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13354"
                    }, 
                    "name": "Marseille University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Nantes University Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Prospective, Non Randomized, Open, Multicenter Trial to Evaluate Non Specific Symptoms and Quality of Life (SF 36) Before and After Surgery for Mild Primary Hyperparathyroidism", 
        "overall_official": {
            "affiliation": "Nantes University Hospital", 
            "last_name": "Eric MIRALLIE, PU\u00a8-PH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: French agency for health products sanitary safety", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "assessment of the evolution of neuropsychic disorders, digestive disorders, asthenia and polydipsia symptoms (non specific symptoms) one year after surgery for patients with moderate HPTI.", 
            "safety_issue": "No", 
            "time_frame": "one year after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01776502"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Evaluation of the quality of life with a quality of life questionnaire (SF36) given preoperatively and at months 3, 6, 12", 
                "safety_issue": "No", 
                "time_frame": "preoperatively and at months 3, 6, 12"
            }, 
            {
                "measure": "evaluation of the evolution of neuropsychic disorders, digestive disorders, asthenia and polydipsia symptoms (non specific symptoms) at months 3 and 6", 
                "safety_issue": "No", 
                "time_frame": "at months 3 and 6"
            }
        ], 
        "source": "Nantes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nantes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2007", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}